Advertisement

Abdominal Radiology

, Volume 43, Issue 11, pp 3009–3015 | Cite as

Cinematic rendering of pancreatic neoplasms: preliminary observations and opportunities

  • Linda C. Chu
  • Pamela T. Johnson
  • Elliot K. Fishman
Pictorial essay

Abstract

Pancreatic cancer is the third most common cause of cancer death and CT is the most commonly used modality for the initial evaluation of suspected pancreatic cancer. Post-processing of CT data into 2D multiplanar and 3D reconstructions has been shown to improve tumor visualization and assessment of tumor resectability compared to axial slices, and is considered the standard of care. Cinematic rendering is a new 3D-rendering technique that produces photorealistic images, and it has the potential to more accurately depict anatomic detail compared to traditional 3D reconstruction techniques. The purpose of this article is to describe the potential application of CR to imaging of pancreatic neoplasms. CR has the potential to improve visualization of subtle pancreatic neoplasms, differentiation of solid and cystic pancreatic neoplasms, assessment of local tumor extension and vascular invasion, and visualization of metastatic disease.

Keywords

Pancreatic neoplasms CT 3D rendering Cinematic rendering 

Notes

Compliance with ethical standards

Conflict of interest

Elliot K. Fishman is a cofounder of HipGraphics and receives institutional Grant support from Siemens Healthcare and GE Healthcare. Linda C. Chu declares that she has no conflict of interest. Pamela T. Johnson declares that she has no conflict of interest.

Ethical approval

This study was in accordance with the ethical standards of the institution and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was waived by the institutional review board for the retrospective study.

References

  1. 1.
    Howlader N, Noone AM, Krapcho M, et al. (2017) SEER cancer statistics review, 1975–2014. National Cancer Institute. https://seer.cancer.gov/csr/1975_2014/. Accessed 22 June 2017
  2. 2.
    NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Pancreatic Adenocarcinoma (2017) National comprehensive cancer network. https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf. Accessed 22 June 2017
  3. 3.
    Al-Hawary MM, Francis IR, Chari ST, et al. (2014) Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology 270(1):248–260.  https://doi.org/10.1148/radiol.13131184 CrossRefPubMedGoogle Scholar
  4. 4.
    Horton KM, Fishman EK (2002) Multidetector CT angiography of pancreatic carcinoma: part 2, evaluation of venous involvement. AJR Am J Roentgenol 178(4):833–836.  https://doi.org/10.2214/ajr.178.4.1780833 CrossRefPubMedGoogle Scholar
  5. 5.
    Horton KM, Fishman EK (2002) Multidetector CT angiography of pancreatic carcinoma: part I, evaluation of arterial involvement. AJR Am J Roentgenol 178(4):827–831.  https://doi.org/10.2214/ajr.178.4.1780827 CrossRefPubMedGoogle Scholar
  6. 6.
    Ichikawa T, Erturk SM, Sou H, et al. (2006) MDCT of pancreatic adenocarcinoma: optimal imaging phases and multiplanar reformatted imaging. AJR Am J Roentgenol 187(6):1513–1520.  https://doi.org/10.2214/AJR.05.1031 CrossRefPubMedGoogle Scholar
  7. 7.
    Manak E, Merkel S, Klein P, et al. (2009) Resectability of pancreatic adenocarcinoma: assessment using multidetector-row computed tomography with multiplanar reformations. Abdom Imaging 34(1):75–80.  https://doi.org/10.1007/s00261-007-9285-2 CrossRefPubMedGoogle Scholar
  8. 8.
    Bluemke DA, Cameron JL, Hruban RH, et al. (1995) Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology 197(2):381–385.  https://doi.org/10.1148/radiology.197.2.7480681 CrossRefPubMedGoogle Scholar
  9. 9.
    Bronstein YL, Loyer EM, Kaur H, et al. (2004) Detection of small pancreatic tumors with multiphasic helical CT. AJR Am J Roentgenol 182(3):619–623.  https://doi.org/10.2214/ajr.182.3.1820619 CrossRefPubMedGoogle Scholar
  10. 10.
    Chen FM, Ni JM, Zhang ZY, et al. (2016) Presurgical evaluation of pancreatic cancer: a comprehensive imaging comparison of CT versus MRI. AJR Am J Roentgenol 206(3):526–535.  https://doi.org/10.2214/AJR.15.15236 CrossRefPubMedGoogle Scholar
  11. 11.
    Fletcher JG, Wiersema MJ, Farrell MA, et al. (2003) Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. Radiology 229(1):81–90.  https://doi.org/10.1148/radiol.2291020582 CrossRefPubMedGoogle Scholar
  12. 12.
    Ichikawa T, Haradome H, Hachiya J, et al. (1997) Pancreatic ductal adenocarcinoma: preoperative assessment with helical CT versus dynamic MR imaging. Radiology 202(3):655–662.  https://doi.org/10.1148/radiology.202.3.9051012 CrossRefPubMedGoogle Scholar
  13. 13.
    Sheridan MB, Ward J, Guthrie JA, et al. (1999) Dynamic contrast-enhanced MR imaging and dual-phase helical CT in the preoperative assessment of suspected pancreatic cancer: a comparative study with receiver operating characteristic analysis. AJR Am J Roentgenol 173(3):583–590.  https://doi.org/10.2214/ajr.173.3.10470884 CrossRefPubMedGoogle Scholar
  14. 14.
    Tamm EP, Loyer EM, Faria SC, et al. (2007) Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer. Abdom Imaging 32(5):660–667.  https://doi.org/10.1007/s00261-007-9298-x CrossRefPubMedGoogle Scholar
  15. 15.
    Megibow AJ, Zhou XH, Rotterdam H, et al. (1995) Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability–report of the Radiology Diagnostic Oncology Group. Radiology 195(2):327–332.  https://doi.org/10.1148/radiology.195.2.7724748 CrossRefPubMedGoogle Scholar
  16. 16.
    Soriano A, Castells A, Ayuso C, et al. (2004) Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol 99(3):492–501.  https://doi.org/10.1111/j.1572-0241.2004.04087.x CrossRefPubMedGoogle Scholar
  17. 17.
    Comaniciu D, Engel K, Georgescu B, Mansi T (2016) Shaping the future through innovations: from medical imaging to precision medicine. Med Image Anal 33:19–26.  https://doi.org/10.1016/j.media.2016.06.016 CrossRefPubMedGoogle Scholar
  18. 18.
    Dappa E, Higashigaito K, Fornaro J, et al. (2016) Cinematic rendering—an alternative to volume rendering for 3D computed tomography imaging. Insights Imaging 7(6):849–856.  https://doi.org/10.1007/s13244-016-0518-1 CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Fellner FA (2016) Introducing cinematic rendering: a novel technique for post-processing medical imaging data. J Biomed Sci Eng 9:170–175CrossRefGoogle Scholar
  20. 20.
    Eid M, De Cecco CN, Nance JW Jr, et al. (2017) Cinematic rendering in CT: a novel, lifelike 3D visualization technique. AJR Am J Roentgenol .  https://doi.org/10.2214/ajr.17.17850 CrossRefPubMedGoogle Scholar
  21. 21.
    Johnson PT, Schneider R, Lugo-Fagundo C, Johnson MB, Fishman EK (2017) MDCT angiography with 3D rendering: a novel cinematic rendering algorithm for enhanced anatomic detail. AJR Am J Roentgenol .  https://doi.org/10.2214/ajr.17.17903 CrossRefPubMedGoogle Scholar
  22. 22.
    Calhoun PS, Kuszyk BS, Heath DG, Carley JC, Fishman EK (1999) Three-dimensional volume rendering of spiral CT data: theory and method. Radiographics 19(3):745–764.  https://doi.org/10.1148/radiographics.19.3.g99ma14745 CrossRefPubMedGoogle Scholar
  23. 23.
    Fishman EK, Ney DR, Heath DG, et al. (2006) Volume rendering versus maximum intensity projection in CT angiography: what works best, when, and why. Radiographics 26(3):905–922.  https://doi.org/10.1148/rg.263055186 CrossRefPubMedGoogle Scholar
  24. 24.
    Rowe SP, Johnson PT, Fishman EK (2017) Initial experience with cinematic rendering for chest cardiovascular imaging. Br J Radiol .  https://doi.org/10.1259/bjr.20170558 CrossRefPubMedGoogle Scholar
  25. 25.
    Rowe SP, Fritz J, Fishman EK (2017) CT evaluation of musculoskeletal trauma: initial experience with cinematic rendering. Emerg Radiol .  https://doi.org/10.1007/s10140-017-1553-z CrossRefPubMedGoogle Scholar
  26. 26.
    Ahn SS, Kim MJ, Choi JY, et al. (2009) Indicative findings of pancreatic cancer in prediagnostic CT. Eur Radiol 19(10):2448–2455.  https://doi.org/10.1007/s00330-009-1422-6 CrossRefPubMedGoogle Scholar
  27. 27.
    Gangi S, Fletcher JG, Nathan MA, et al. (2004) Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis. AJR Am J Roentgenol 182(4):897–903.  https://doi.org/10.2214/ajr.182.4.1820897 CrossRefPubMedGoogle Scholar
  28. 28.
    Zaky AM, Wolfgang CL, Weiss MJ, et al. (2017) Tumor-vessel relationships in pancreatic ductal adenocarcinoma at multidetector CT: different classification systems and their influence on treatment planning. Radiographics 37(1):93–112.  https://doi.org/10.1148/rg.2017160054 CrossRefPubMedGoogle Scholar
  29. 29.
    Chang ST, Jeffrey RB, Patel BN, et al. (2016) Preoperative multidetector CT diagnosis of extrapancreatic perineural or duodenal invasion is associated with reduced postoperative survival after pancreaticoduodenectomy for pancreatic adenocarcinoma: preliminary experience and implications for patient care. Radiology 281(3):816–825.  https://doi.org/10.1148/radiol.2016152790 CrossRefPubMedGoogle Scholar
  30. 30.
    Dal Molin M, Blackford AL, Siddiqui A, et al. (2017) Duodenal involvement is an independent prognostic factor for patients with surgically resected pancreatic ductal adenocarcinoma. Ann Surg Oncol 24(8):2379–2386.  https://doi.org/10.1245/s10434-017-5864-9 CrossRefGoogle Scholar
  31. 31.
    Mahadevan A, Jain S, Goldstein M, et al. (2010) Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 78(3):735–742.  https://doi.org/10.1016/j.ijrobp.2009.08.046 CrossRefPubMedGoogle Scholar
  32. 32.
    Touzios JG, Kiely JM, Pitt SC, et al. (2005) Neuroendocrine hepatic metastases: does aggressive management improve survival? Ann Surg 241(5):776–783 (discussion 783–775)CrossRefGoogle Scholar
  33. 33.
    Vogl TJ, Mohamed SA, Albrecht MH, et al. (2017) Transarterial chemoembolization in pancreatic adenocarcinoma with liver metastases: MR-based tumor response evaluation, apparent diffusion coefficient (ADC) patterns, and survival rates. Pancreatology .  https://doi.org/10.1016/j.pan.2017.11.014 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.The Russell H. Morgan Department of Radiology and Radiological ScienceJohns Hopkins UniversityBaltimoreUSA

Personalised recommendations